Magnetic Resonance Spectroscopic Imaging (MRSI) using hyperpolarized tracers [1-13 C]pyruvate provided an imaging biomarker which delineates the tumor on the basis of aerobic glycolysis by monitoring the conversion of injected pyruvate to the metabolic product lactate. In two tumor cell lines implanted in mice, lactate/pyruvate ratios were monitored before, during and after fractionated radiotherapy. The lactate/pyruvate ratios significantly responded to radiation in HT-29 tumors, which are relatively less hypoxic, whereas the response in the relatively more hypoxic SCCVII tumor was modest. The response to radiotherapy measured as tumor regrowth delay was in agreement with the response of the lactate/pyruvate: the regrowth delay was longer and more profound in HT-29 tumors than SCCVII tumors. [1-
Introduction
Radiation therapy is widely used for cancer treatment. The efficacy of radiotherapy is mainly evaluated by the shrinkage of tumor volume, but it can take weeks to detect such changes.
The anatomical information obtained by computed tomography (CT) and magnetic resonance imaging (MRI) is important and is widely used for the diagnosis and localization of tumors, but these modalities are not suitable for detecting early responses to treatment (1, 2) . Therefore, imaging biomarkers for monitoring early response to radiotherapy are desired to provide more effective treatments. Irradiation can induce diverse effects on the tumor microenvironment, such as changes in perfusion, oxygenation, and metabolism, in addition to killing tumor cells (3) (4) (5) (6) (7) .
Changes in the tumor microenvironment can serve as useful markers for assessing the efficacy of radiotherapy because these changes occur in advance of tumor shrinkage (8,9). Although several modalities exist that can monitor changes in the tumor microenvironment, such as dynamic contrast-enhanced MRI (DCE-MRI) (10,11) and 18 F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) (12,13), new MRI-based approaches are being explored that could provide anatomically co-registered metabolic/physiologic information (14, 15) .
Hyperpolarized MRI could provide us with the ability to monitor the metabolic processes of hyperpolarized substrates in live animals and humans (15) (16) (17) . Several studies using hyperpolarized [1- 13 C]pyruvate have shown that lactate formation from pyruvate was significantly higher in tumors compared with normal tissues, and it decreased with treatments, such as PI3K inhibitors and antiangiogenic agents (8, (18) (19) (20) . A recent study using transgenic mice of prostate cancer was able to distinguish between responders and non-responders to androgen deprivation therapy based on the changes of Lac/Pyr ratio before and after treatment suggesting that this imaging biomarker can be a useful non-invasive tool in monitoring treatment
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Author Manuscript Published OnlineFirst on February 11, 2015; DOI: 10.1158/1078-0432.CCR-14-1717 5 response (21) . These studies clearly demonstrated that hyperpolarized 13 C-MRI using [1- 13 C]pyruvate was a promising approach for detecting early changes in tumor metabolism.
In this study, we investigated tumor response to radiotherapy in squamous cell carcinoma (SCCVII) and the HT-29 colon cancer xenograft model using hyperpolarized 13 C-MRI with [1-
13 C]pyruvate. These two cell lines as implants have been recently studied to characterize tumor oxygenation and blood flow . Thus, these two tumors could serve as useful models to investigate the feasibility of early detection of treatment response to radiation by 13C MRSI using [1-
13 C]pyruvate.
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Materials and Methods

Animal studies
All of the animal experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animal Resources (National Research Council, 1996) were measured by a digital caliper, and the volume was calculated by length × width 2 × π/6. The radiation doses used in this study were based on the results obtained in these cells in in vitro and in vivo studies (25) . The growth of SCCVII tumors (n=7 for each control group and irradiated group) and HT-29 tumors (n=7 for each control group and irradiated group) were monitored until they exceeded 1800 mm 3 or they were not visually observed after radiotherapy. The 13 C-MRI studies and X-ray treatments was initiated 8 days and 10 days after tumor cell implantation with SCCVII and HT-29 tumor cells, respectively. The tumor volumes were 600-750 mm 3 at the beginning of the experiments. The mice were anesthetized with isoflurane (4 % for induction and 1.5-2.5 % for maintaining anesthesia) in medical air (500 mL/min) and were positioned prone with their tumor-bearing legs placed inside the resonator. During MRI measurements, the breathing rate of the mouse was monitored with a pressure transducer (SA Instruments Inc., Stony Brook, NY) and was maintained at 80 ± 10 breaths per minute. Core body temperature was also monitored with a non-magnetic rectal temperature probe (FISO) and was maintained at 36 ± 1°C with a flow of warm water. For the dynamic study, 13 C spectra were acquired every 1sec for 240 sec from a 8-12 mm slice on the SCCVII (n=4 for control and n=6 for irradiated group) and HT-29 (n=5 for each control and irradiated group). The slice thickness was defined as it included most part of the tumor. 13 C
Electron paramagnetic resonance (EPR) imaging
Tumor pO 2 maps in SCCVII tumor (n=5) and HT-29 tumor (n=4) were obtained using EPR imaging. Technical details of the EPR scanner operating at 300 MHz, data acquisition based on the single-point imaging (SPI) modality, image reconstruction, and oxygen mapping procedure have been described in earlier reports (27, 28) . After the animal was placed in the resonator, a triarylmethyl radical probe (OX063, GE Healthcare) was injected intravenously as a images was accomplished using code written in MATLAB (Mathworks), as described in a previous report (28) .
Western blot and LDH activity assay
The mice (n=3 for each group) were euthanized by breathing carbon dioxide gas, and 5-10 mm 3 
Colony formation assay
on July The mice (n=3 for each group) were euthanized by breathing carbon dioxide gas, and 5-10 mm 3 tumor biopsy samples were excised. The tumor tissues were immediately minced with scissors and were digested by 0.2 % collagenase/0.02 % deoxyribonuclease solution to yield single-cell suspensions. The cells were counted and seeded in culture dishes at concentrations of 250-10,000 cells/dish for colony formation. Ten days later, the colonies were stained with crystal violet dye, and the numbers of colonies were counted.
X-ray irradiation
The mice were fixed in a specially designed jig for X-ray irradiation in which they were restricted from moving without anesthesia. X-ray irradiation (10 Gy) was delivered to the tumorbearing leg 8, 9, and 10 days after SCCVII tumor implantation and 10, 11, and 12 days after HT-29 implantation, using a XRAD-320 (Precision X-ray Inc., North Branford, CT).
Statistical analysis
All of the results are expressed as the means ± SEMs. The differences in the means of groups were determined by Student's 2-tailed t test. The minimum level of significance was set at p <0.05.
Results
Tumor pO 2 and growth suppression by X-ray irradiation
In this study, two types of tumors, SCCVII murine carcinoma and HT-29 human colon carcinoma, were used to examine metabolic changes caused by X-ray irradiation. As shown in a previous study, these tumors differed in their microenvironmental features, such as oxygenation and blood vessel integrity (29) . Figure 1C shows the growth curves of the non-irradiated SCCVII tumors and the fractionated 30 Gy (10 Gy × 3) irradiated tumors. X-ray irradiation was started 8 days after tumor implantation. The doubling time of the non-irradiated SCCVII tumor was found to be 2.7 ± 0.2 days. Tumor suppression was confirmed 2 days after the beginning of irradiation, and the growth was delayed for 5 days by 30 Gy of irradiation. X-ray irradiation to HT-29 tumors was started 10 days after tumor implantation when the tumor size was similar to that on Day 8 with the SCCVII tumors.
The doubling time of the non-irradiated HT-29 tumor was found to be 4.9 ± 0.6 days. The growth kinetics of the irradiated HT-29 tumors were almost same as the those of the nonirradiated control tumors until 1 day after fractionated 30 Gy irradiation, after which the tumor shrank (Fig. 1D) . The difference in radiation response in these two tumors was consistent with
the relatively higher median pO 2 of the HT-29 tumors compared to the SCCVII tumors as well as the better blood flow characteristics (29) .
Lactate formation from pyruvate in tumors measured using hyperpolarized 13 
C-MRI was decreased by X-irradiation
To evaluate the effects of X-ray irradiation on pyruvate metabolism, 13 C-MR spectroscopic measurements were carried out in SCCVII tumor-bearing mice. Hyperpolarized pyruvate to lactate both in vitro and in vivo (33) . So, we used AUC to quantify the lactate formation from pyruvate.
Longitudinal changes in Lac/Pyr in non-irradiated control SCCVII tumors and X-ray irradiated tumors were examined using hyperpolarized 13 hyperpolarized [1- 13 C]pyruvate injection (Fig. 4A,D) . Figure 4B and E show maps of total 13 (Fig. 4C,F) . The median value of Lac/Pyr in the tumor region, calculated from chemical shift images, showed drop of lactate formation by the radiation that is similar to the results of 
LDH activity and protein levels were decreased by X-ray irradiation
Independent ex vivo measurements, using an extract of SCCVII tumor, revealed that LDH activity was significantly lower in 30 Gy-irradiated tumors compared to non-irradiated tumors.
The results of western blotting showed that the LDH-A protein levels in irradiated tumors were 38 % lower than in non-irradiated control tumors (Fig. 5A,B) . LDH activity, measured by NADH consumption in the presence of pyruvate, was also smaller in the irradiated tumors (1.15 ± 0.03 μmol NADH/min/mg protein) compared with the control tumors (1.52 ± 0.06 μmol NADH/min/mg protein), indicating that a decrease in LDH activity was one of the factors responsible for the decrease in lactate formation observed in 13 C-MRI (Fig. 5C ). Tumor cell survival, assessed by the colony formation assay, revealed significant cell killing in tumors after irradiation. The colony-forming ability of SCCVII tumors after 10 and 30 Gy of irradiation was decreased by 44 % and 91 %, respectively compared with that of the non-irradiated control tumors (Fig. 5D) . The colony forming ability of HT-29 was decreased by radiation to a larger
Research. were stronger in HT-29 tumors than in SCCVII tumors: that is, at 1 day after the 3 fractions of radiation, lactate to pyruvate ratio in the HT-29 tumor measured by 13 C-MRS decreased by 37 % compared with that before radiation, whereas it decreased by 15 % in the SCCVII tumor (Fig. 3) .
Lac/Pyr in SCCVII tumors was significantly smaller in the irradiated group compared with the day-matched control group, but there was no significance compared with that before irradiation.
In contrast, Lac/Pyr significantly decreased in treated tumors compared with before irradiation in HT-29 tumors (Fig. 3B) . It is well known that the efficacy of radiotherapy depends on pretreatment tumor oxygenation (35) (36) (37) . The strong effects of irradiation on HT-29 growth and pyruvate metabolism could be attributed to higher oxygenation (Fig. 1B) . The increase in Lac/Pyr in non-irradiated SCCVII tumors from Day 8 to Day 11 was also consistent with previous studies (38, 39) that showed that SCCVII tumors became more hypoxic as tumors grew, with LDH expected to increase because it is a downstream protein of HIF-1.
LDH protein levels and activity significantly decreased in irradiated tumors (Fig. 5B, C) .
This decrease in LDH protein would have resulted from the potent cytocidal effects of 30 Gy
irradiation, which were further confirmed by colony formation assay (Fig. 5D) . In addition to LDH, monocarboxylate transporters (MCTs), which transport pyruvate into tumor cells, affect the rate of lactate conversion from pyruvate. Although the radiation-induced changes in the MCTs were not monitored in this study, it was expected that MCT proteins were also reduced by C maps showed a lack of the 13 C signal in some regions of the SCCVII tumors after the 30 Gy irradiation, whereas the 13 C signal was observed throughout the tumors before irradiation (Fig. 4B) . It was not possible to quantify the blood flow using hyperpolarized 13 C-MRI because the 13 C signal intensity was influenced by the magnitude of polarization. However, the lack of the 13 C signal indicated that tumor perfusion was altered by irradiation, at least in that region.
In conclusion, 13 Lac/Pyr was mainly attributed to the decrease in LDH activity due to cell death caused by irradiation. Further studies using lower dose rates are necessary to assess the effects of irradiation on tumor metabolism because the dose rate used in this study (10 Gy × 3) was higher than that used clinically.
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